Diagnostic companies develop tests and technologies that enable early detection and accurate diagnosis of cancer. These tests can identify specific genetic mutations, biomarkers, and other indicators of cancer, allowing for more personalized and effective treatment plans. Companies like Illumina and Foundation Medicine are leaders in the field of cancer diagnostics, providing tools that enhance the precision of cancer care.
